Sydney - June 24, 2015 - Australian stem cell company Genea Biocells is opening a new facility in San Diego, California. The new premises are located in the Torrey Pines Science Park and include office and laboratory space to accommodate the company’s cell and culture media manufacturing, research services and R&D.
“This is an exciting strategic move and the next step to grow Genea Biocells into a world leading stem cell company. The new facility not only places us directly into our main market, the USA, but also in the midst of one of the largest biotechnology clusters in the world,” Genea Biocells General Manager Dr Uli Schmidt said.
The move represents a substantial investment in California with the new site housing over US$2 million worth of equipment, including sophisticated robotics and instrumentation for high-throughput/high-content screening. The site is expected to be fully operational from September 2015 and by early 2016 will house up to 15 scientists, the majority of whom are PhD-level.
According to BIOCOM, the region’s Life Science Trade Association, the San Diego area is home to more than 900 biotech companies as well as over 80 research institutes, including The Scripps Research Institute, University of California San Diego and the Salk Institute for Biological Sciences.
Genea Biocells focuses on therapeutics discovery research for neuromuscular diseases using proprietary human pluripotent stem cell technologies.